GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hospital Mater Dei SA (BSP:MATD3) » Definitions » Research & Development

Hospital Mater Dei (BSP:MATD3) Research & Development : R$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Hospital Mater Dei Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hospital Mater Dei's Research & Development for the three months ended in Mar. 2025 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was R$0 Mil.

Hospital Mater Dei Research & Development Historical Data

The historical data trend for Hospital Mater Dei's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hospital Mater Dei Research & Development Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial - - - - -

Hospital Mater Dei Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hospital Mater Dei Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei  (BSP:MATD3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hospital Mater Dei Research & Development Related Terms

Thank you for viewing the detailed overview of Hospital Mater Dei's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Hospital Mater Dei Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hospital Mater Dei SA (BSP:MATD3) » Definitions » Research & Development
Comparable Companies
BSP:ONCO3 HCA XTER:FRE SAU:4013 XTER:FME SZSE:300015 THC BSP:RDOR3 XKLS:5225 BOM:543220 UHS EHC NSE:APOLLOHOSP BKK:BDMS DVA CHE ENSG ADX:PUREHEALTH BOM:532843 ASX:RHC
Traded in Other Exchanges
N/A
Address
Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Website
https://ri.materdei.com.br
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. It has a capacity of more than a thousand hospital beds in three hospital units strategically located in the metropolitan region of the city of Belo Horizonte.

Hospital Mater Dei Headlines

No Headlines